1999

I analysed the results of a randomised controlled trial that had just been completed by some of my colleagues. The trial compared an oxygen radical scavenger with a placebo in patients with acute myocardial infarction. One of the major outcome measures included infarct size,as measured by nuclear imaging.

A paper published in journal A in 1990 was published almost verbatim in journal B the following year, and yet again in journal C in 1993. None of these publications made any reference to the others. The case emerged in the process of one of the authors applying for a professorship. The authors conceded their error when tackled on the issue. One editor agreed to publish notice of duplicate publication, but difficulties were experienced tracking down the third editor.

A consultant in public health and a consultant clinical biochemist employed by a health authority submitted a paper. It sought to address the question of benzodiazepine abuse and re-sale on the black market.

A paper from Taiwan was reviewed and accepted for publication. However, one of the reviewers raised the question of ethics committee approval. When the editors checked with the authors, they responded that there is no ethics committee at their university and they were therefore not able to seek ethical approval. What is COPE’s view on this? The study was fairly straightforward involving a questionnaire, some simple lung function, skin, and blood tests.

A paper by Turkish authors was submitted to journal A. The paper was virtually the same as one published in the equivalent US journal B of the same specialty,but with different authors. The paper submitted to journal A seems to have been plagiarised from the paper published in journal B. The editor has written to the deans of the faculties of medicine to which the authors are attached. What more should he do?

A paper was published for which the authors’contributions were as follows: A and B had the original idea and planned the study. A was also responsible for collecting the samples and patient data. C established the database and participated in planning the clinical trial. D developed the enzyme linked immunoabsorbent assay and analysed all the samples. E and F were responsible for the statistical analyses of the data. The paper had been written jointly by B, G, D, H and A.

A paper was published in January 1998,and seven authors were credited. B was thanked for his contribution in the acknowledgements section. One year later B wrote to the editor, outlining two alleged incidents related to this paper. First, the cohort reported in the January 1998 paper was one that B had been working on since the early 1990s. In 1992–3 he sought collaboration with another research group. A grant was applied for and granted.